These are not the only impact analyst calls this morning, but these are the top calls that a673b.bigscoots-temp.com is focusing on:
ABB Ltd. (NYSE: ABB) downgraded to SELL from Hold at Citigroup.
Amylin Pharma (NASDAQ:AMLN) started as Outperform at Robert Baird.
Arena Pharamaceuticals (NASDAQ:ARNA) raised to Buy from Neutral at Banc of America.
BP plc (NYSE: BP) downgraded to Underweight from Equal Weight at Lehman Brothers.
Electronics for Imaging (NASDAQ:EFII) downgraded to Neutral from Buy at Banc of America.
Metlife (NYSE: MET) raised to Outperform from Market Perform at Bernstein.
NVIDIA (NASDAQ:NVDA), LSI (NYSE: LSI), NetLogic (NASDAQ:NETL) and Xilinx (NASDAQ:XLNX) all downgraded to HOLD from Buy at Deutsche Bank.
StatoilHydro (NYSE: STO) raised to Outperform from neutral at Credit Suisse.
Total SA (NYSE: TOT) downgraded to Neutral from Outperform at Credits Suisse.
Wells Fargo (NYSE: WFC) downgraded to Underperform from Market Perform at FBR.
Jon C. Ogg January 15, 2008
“The Next NVIDIA” Could Change Your Life
NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.
But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.